The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies

Telomere Length Clinical Trial

Official title:
The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies

Status Active, not recruiting

Clinical Trial Summary

The telomere system stabilizes the chromosomes. Telomeres are shortened during senescence, in cases of genetic instability and secondary to stress.

The investigators aim is to study the telomere system in cord blood and in the placenta immediately after the delivery in pregnancies defined as high risk pregnancies following sterss events such as placental insufficiency, preeclampsia, diabetes.

The investigators intend to compare the telomere system in maternal blood to cord blood and to placental biopsies and to study the influence of different stressogenes on this system.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

High Risk Pregnancies
Mechanisms of Telomter Homeostasis
Telomere Length

Clinical Trial Details

NCT number	NCT01384136
Study type	Observational
Source	Meir Medical Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	June 2011
Completion date	June 2015

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04577560` - Telomere Length in Human Polar Body and Telomere Length in Cumulus Cells: A Clinical Validation Study	N/A
	Active, not recruiting	`NCT06357663` - Subtle Energy Transmission and Tao Calligraphy Mindfulness in Telomere Length in Peripheral Blood Leukocytes	N/A